Skip to main content
ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · IEX Real-Time Price · USD
0.311
+0.021 (7.24%)
May 2, 2024, 2:28 PM EDT - Market open

ENDRA Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019201820172016
Market Capitalization
31813291913819-
Market Cap Growth
-39.42%-55.93%54.93%49.09%55.17%-57.14%--
Enterprise Value
1159201272131
PE Ratio
-1.78-1.78-0.97-2.57-1.55-0.72-0.83-3.53-
PS Ratio
------1318.1754.01-
PB Ratio
0.623.171.782.712.632.651.303.60-
P/FCF Ratio
-1.87-1.87-0.99-2.61-1.74-1.46-1.04-5.74-
P/OCF Ratio
-1.88-1.88-1.01-2.62-1.75-1.47-1.06-5.75-
EV/Sales Ratio
------270.0038.071.56
EV/EBITDA Ratio
-1.58-1.58-0.66-1.85-1.06-0.54-0.17-2.52-0.30
EV/EBIT Ratio
-1.54-1.54-0.65-1.82-1.05-0.54-0.17-2.49-0.29
EV/FCF Ratio
-1.62-1.62-0.66-1.83-1.14-0.83-0.21-4.05-0.61
Debt / Equity Ratio
0.070.070.080.060.100.15---1.06
Debt / EBITDA Ratio
-0.04-0.04-0.04-0.06-0.06-0.05---0.35
Debt / FCF Ratio
-0.04-0.04-0.04-0.06-0.06-0.08---0.72
Quick Ratio
3.143.142.876.137.332.986.646.610.10
Current Ratio
3.363.363.167.838.323.157.136.940.14
Asset Turnover
0000000.000.061.06
Return on Equity (ROE)
-180.60%-180.60%-132.40%-80.00%-346.20%-594.60%-371.00%-114.10%862.60%
Return on Assets (ROA)
-133.00%-133.00%-110.10%-70.60%-226.70%-376.50%-256.90%-97.40%-567.90%
Return on Capital (ROIC)
-173.80%-173.80%-169.75%-99.94%-146.54%-196.36%-144.35%-101.92%-4927.23%
Earnings Yield
-287.66%-56.13%-102.51%-38.92%-64.38%-138.78%-120.37%-28.32%-
FCF Yield
-273.75%-53.41%-100.90%-38.28%-57.48%-68.36%-95.87%-17.42%-
Buyback Yield / Dilution
-120.10%-120.10%-41.31%-113.23%-155.90%-66.49%-63.40%-281.17%68.82%
Total Shareholder Return
-120.10%-120.10%-41.31%-113.23%-155.90%-66.49%-63.40%-281.17%68.82%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).